Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Targeted Oncology
|
March 8, 2024
Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia-A Podcast
Elias J Jabbour, Matthias Stelljes
Leukemia Research
|
February 9, 2013
Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib
Alfonso Quintás-Cardama, Elias J Jabbour
Leukemia & Lymphoma
|
January 26, 2012
Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response
Elias J Jabbour, Alfonso Quintás-Cardama
Current Hematology Reports
|
May 4, 2005
New agents in myelodysplastic syndromes
Elias J Jabbour, Francis J Giles
Drugs & Aging
|
August 20, 2015
Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments
Jeffrey C Bryan, Elias J Jabbour
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2019
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Selim Corbacioglu, Elias J Jabbour, Mohamad Mohty
Mayo Clinic Proceedings
|
November 6, 2016
Adult Acute Lymphoblastic Leukemia
Shilpa Paul, Hagop Kantarjian, Elias J Jabbour
Mayo Clinic Proceedings
|
November 22, 2005
Adult acute lymphoblastic leukemia
Elias J Jabbour, Stefan Faderl, Hagop M Kantarjian
Expert Opinion on Pharmacotherapy
|
April 5, 2015
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
Morgan L Mace, Jenny Dahl, Elias J Jabbour
British Journal of Haematology
|
December 13, 2019
The face of remission induction
Shilpa Paul, Caitlin R Rausch, Elias J Jabbour
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Targeted Oncology
|
March 8, 2024
Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia-A Podcast
Elias J Jabbour, Matthias Stelljes
Leukemia Research
|
February 9, 2013
Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib
Alfonso Quintás-Cardama, Elias J Jabbour
Leukemia & Lymphoma
|
January 26, 2012
Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response
Elias J Jabbour, Alfonso Quintás-Cardama
Current Hematology Reports
|
May 4, 2005
New agents in myelodysplastic syndromes
Elias J Jabbour, Francis J Giles
Drugs & Aging
|
August 20, 2015
Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments
Jeffrey C Bryan, Elias J Jabbour
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2019
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Selim Corbacioglu, Elias J Jabbour, Mohamad Mohty
Mayo Clinic Proceedings
|
November 6, 2016
Adult Acute Lymphoblastic Leukemia
Shilpa Paul, Hagop Kantarjian, Elias J Jabbour
Mayo Clinic Proceedings
|
November 22, 2005
Adult acute lymphoblastic leukemia
Elias J Jabbour, Stefan Faderl, Hagop M Kantarjian
Expert Opinion on Pharmacotherapy
|
April 5, 2015
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
Morgan L Mace, Jenny Dahl, Elias J Jabbour
British Journal of Haematology
|
December 13, 2019
The face of remission induction
Shilpa Paul, Caitlin R Rausch, Elias J Jabbour
Page
of 16